Serum thrombopoietin levels in relation to disease status in patients with immune thrombocytopenic purpura

Br J Haematol. 2001 Dec;115(4):1004-6. doi: 10.1046/j.1365-2141.2001.03184.x.

Abstract

Pre- and post-treatment serum thrombopoietin (TPO) concentration was measured in 35 patients with immune thrombocytopenic purpura (ITP). Mean post-treatment levels were significantly lower (P = 0.02) than pretreatment and not different for treatment modality. No significant correlation between pre- or post-treatment TPO and platelet counts was demonstrable (R = -0.325, P = 0.056 and R = -0.227, P = 0.190 respectively). In patients with very low platelet counts (< or =20 x 10(9)/l), pretreatment serum TPO was significantly higher than in patients with higher counts (P = 0.033). The logarithm of the platelet turnover rate, measured in 15 patients, correlated with pretreatment TPO levels (R = 0.64). These findings suggest a contributory role for TPO in the mechanism of ITP.

MeSH terms

  • Blood Platelets / physiology*
  • Glucocorticoids / therapeutic use
  • Humans
  • Immunoglobulins, Intravenous / therapeutic use
  • Interferon alpha-2
  • Interferon-alpha / therapeutic use
  • Platelet Count
  • Purpura, Thrombocytopenic, Idiopathic / blood*
  • Purpura, Thrombocytopenic, Idiopathic / therapy
  • Recombinant Proteins
  • Splenectomy
  • Statistics, Nonparametric
  • Thrombopoietin / analysis*

Substances

  • Glucocorticoids
  • Immunoglobulins, Intravenous
  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins
  • Thrombopoietin